A radiobiological review on melatonin: A novel radioprotector

Journal of Radiation Research

Volumn 48, Issue 4, 2007, Pages 263-272

  Shirazi, Alireza ^a   Ghobadi, Ghazaleh ^a,b   Ghazi Khansari, Mahmoud ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ionizing radiation; Melatonin; Radiobiology; Radioprotective; Radiotherapy; Repair enzyme

Indexed keywords

CELL SIGNALING; DISEASES; ENZYMES; HORMONES; RADIATION EFFECTS; RADIATION SHIELDING; RADIOACTIVITY; RADIOTHERAPY; REPAIR; TISSUE;

DAMAGING EFFECTS; EFFECTIVE TOOL; EXPOSED TO; LIVING THINGS; NORMAL TISSUE; RADIATION-INDUCED; RADIOPROTECTIVE; RADIOPROTECTORS; REPAIR ENZYMES; THERAPEUTIC RATIOS;

IONIZING RADIATION;

EID: 34547107081     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.06070     Document Type: Review

References (65)

1. Steel, G. G. (2002) Basic Clinical Radiobiology, Third edition, Edward Arnold Publishers.
2. Nair, C. K. K., Parida, D. K. and Nomura, T. (2001) Radioprotectors in Radiotherapy. J. Radiat. Res. 42: 21-37.
3. Taysi, S., Koc, M., Buyukokuroglu, M. E., Alt?nkaynak, K. and Sahin, Y. N. (2003) Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver. J. Pineal Res. 34: 173-177.
4. Dawson, L. A., Normolle, D., Balter, J. M., McGinn, C. J., Lawrence, T. S. and Ten Haken, R. K. (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 53: 810-821.
5. Koc, M., Taysi, S., Emin Buyukokuroglu, M. and Nuri Sahin, Y. (2003) Melatonin Protects Rat Liver against Irradiation-induced Oxidative Injury. J. Radiat. Res. 44: 211-215.
6. Hall, E J. (2000) Radiobiology for the Radiobiologist, Fifth edition, J. B. Lippincott Compony.
7. Vijayalaxmi, Reiter, R. J., Tan, D. X., Herman, T S. and Thomas, J. R. C. R. (2004) Melatonin As A Radioprotective Agent: A Review. Int. J. Radiation Oncology Biol. Phys. 59: 639-653.
8. Zhang, B., Su, Y., Ai, G., Wang, Y., Wang, T. and Wang, F. (2005) Involvement of Peroxiredoxin I in Protecting Cells from Radiation-Induced Death. J. Radiat. Res. 46: 305-312.
9. Karbownik, M. and Reiter, R. J. (2000) Antioxidative Effects of Melatonin in Protection Against Cellular Damage Caused by Ionizing Radiation. Proceedings of the Society for Experimental Biology and Medicine. 225: 9-22.
10. Zhou, G., Kawata, T., Furusawa, Y., Aoki, M., Hirayama, R. ando, K. and Ito, H. (2006) Protective Effects of Melatonin Against Low- and High-LET Irradiation. J. Radiat. Res. 47: 175-181.
11. Kasai, H., Crain, P. F., Kuchino, Y., Nishimura, S. A., Ootsuyama, and Tanooka, H. (1986) Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis. 7: 1849-1851.
12. Gajewski, E., Rao, G., Nackerdien, Z. and Dizdaroglu, M. (1990) Modification of DNA bases in mammalian chromatin by radiation-generated free radicals. Biochemistry. 29: 7876-7882.
13. Wood, ML., Dizdaroglu, M., Gajewski, E. and Essigmann, J. M. (1990) Mechanistic studies of ionizing radiation and oxidative mutagenesis: Genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry. 29: 7024-7032.
14. Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S. and Loeb, L. A. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and and A→X substitutions. J Biol Chem. 267: 166-172.
15. Tchou, J. and Grollman, A. P. (1993) Repair of DNA containing the oxidatively damaged base, 8-oxoguanine. Mutat Res. 299: 277-287.
16. Floyd, R. A. (1990) The role of 8-hydroxydeoxyguanosine in carcinogenesis. Carcinogenesis. 11: 1447-1450.
17. Fischer-Nielsen, A., Jeding, I. B. and Loft, S. (1994) Radiation-induced formation of 8-hydroxy-2′-deoxyguanosine and its prevention by scavengers. Carcinogenesis. 15: 1609-1612.
18. Haegele, A. D., Wolfe, P. and Thompson, H. J. (1998) X-radiation induces 8-hydroxy-2′-deoxyguanosine formation in vivo in rat mammary gland DNA. Carcinogenesis. 19: 1319-1321.
19. Elia, M. C., DeLuca, J. G. and Bradley, M. O. (1991) Significance and measurement of DNA double strand breaks in mammalian cells. Pharmacol Ther. 51: 291-327.
20. Sankaranarayanan, K. (1999) Ionizing radiation and genetic risks X. The potential "disease phenotypes" of radiation-induced genetic damage in humans: Perspectives from human molecular biology and radiation genetics. Mutat Res. 429: 45-83.
21. Olivieri, G., Bodycote, J. and Wolff, S. (1984) Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science. 223: 594-597.
22. Vijayalaxmi, Reiter, R. J. and Meltz, M. L. (1995) Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res. 346: 23-31.
23. Vijayalaxmi, Reiter, R. J., Sewerynek, E., Poeggeler, B., Leal, B. Z. and Meltz, M. L. (1995) Marked reduction of radiation-induced micronuclei in human blood lymphocytes pre-treated with melatonin. Radiat Res. 143: 102-106.
24. Vijayalaxmi, Reiter, R. J., Herman, T. S. and Meltz, M. L. (1996) Melatonin and radioprotection from genetic damage: In vivo/in vitro studies with human volunteers. Mutat Res. 371: 221-228.
25. Vijayalaxmi, Reiter, R. J., Herman, T. S. and Meltz, M. L. (1998) Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutat Res. 397: 203-208.
26. Vijayalaxmi, Reiter, R. J., Meltz, M. L. and Herman, T. S. (1998) Melatonin: Possible mechanisms involved in its 'radioprotective' effect. Mutat Res. 404: 187-189.
27. Edwards, J. C., Chapman, D., Cramp, W. A. and Yatvin, M. B. (1984) The effects of ionizing radiation on biomembrane structure and function. Prog Biophys Mol Biol. 43: 71-93.
28. Verma, S. P. and Sonwalker, N. (1991) Structural changes in plasma membranes prepared from irradiated Chinese hamster V79 cells as revealed by Raman spectroscopy. Radiat Res. 126: 27-35.
29. Taysi, S., Uslu, C., Akcay, F. and Sutbeyaz, M. Y. (2003) Malondialdehyde and Nitric Oxide Levels in the Plasma of Patients with Advanced Laryngeal Cancer. Surg. Today. 33: 651-654.
30. Bakan, E., Taysi, S., Polat, M. F., Dalga, S., Umudum, Z., Bakan, N. and Gumus, M. (2002) Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol. 32: 162-166.
31. Dale, W. M., Gray, L. H. and Meredith, W. J. (1949) The inactivation of an enzyme (Carboxypeptidase) by X- and α-radiation. Philos Trans R Soc Lond A Math Phy Sci. 242: 33-62.
32. Patt, H. M., Tyree, E. B., Straube, R. L. and Smith, D. E. (1949) Cysteine protection against X irradiation. Science. 110: 213-214.
33. Becq, Z. M., Herve, A. and Lecomte, J. (1951) Protection contre le rayonnement X par la [graphic not provided] mercaptoethylamine. Arch Int Physiol. 59: 442-447.
34. Bump, E. A. and Malakar, K. (1997) Radioprotectors: Chemical, biological and clinical perspectives. Eds. Bump EA, Malakar K., Boca Raton: CRC Press.
35. Yuhas, J. M., Spellman, J. M. and Culo, F. (1980) The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials. 3: 211-216.
36. Glover, D. J., Riley, L., Carmichael, K., Spar, B., Glick, J., Kligerman, M. M., Agus, Z. S., Slatopolsky, E., Attie, M. and Goldfarb, S. (1983) Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent). N Engl J Med. 309: 1137.
37. Kligerman, M. M., Glover, D. J., Turrisi, A. T., Norfleet, A. L., Yuhas, J. M., Coia, L. R., Simone, C., Glick, J. H. and Goodman, R. L. (1984) Toxicity of WR-2721 administered in single and multiple doses. Int J. Radiat Oncol Biol. Biophys. 10: 1773-1776.
38. Schuchter, L. M. and Glick, J. H. (1993) The current status of WR-2721 (amifostine): A chemotherapy and radiotherapy protector. In: Biologic therapy of cancer updates. EDs. DeVita, VT. Hellman, S. and Rosenberg, SA. pp. 1-10, Philadelphia, Lippincott.
39. Vijayalaxmi, Meltz, M. L., Reiter, R. J., Herman, T. S. and Kumar, K. S. (1999) Melatonin and protection from whole-body irradiation: survival studies in mice. Mutation Research. 425: 21-27.
40. Lane, E. A. and Moss, H. B. (1985) Pharmacokinetics of melatonin in man: First pass hepatic metabolism. J Clin Endocrinol Metab. 61: 1214-1216.
41. Vijayalaxmi, Meltz, M. L. and Reiter, R. J. (1999) Melatonin and protection from whole-body irradiation: Survival studies in mice. Mutat Res. 425: 21-27.
42. Vijayalaxmi, Meltz, M. L. and Reiter, R. J. (1999) Melatonin and protection from genetic damage in blood and bone marrow: Whole-body irradiation studies in mice. J Pineal Res. 27: 221-225.
43. Jahnke, G., Marr, M., Myers, C., Wilson, R., Travlos, G. and Price, C. (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague Dawley rats. Toxicol Sci. 50: 271-279.
44. Kaya, H., Delibas, N., Serteser, M., Ulukaya, E. and Ozkaya, O. (1999) The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol. 175: 285-288.
45. Karslioglu, I., Ertekin, M. V., Taysi, S., Kocer, I., Sezen, O., Gepdiremen, A., Koc, M. and Bakan, N. (2005) Radioprotective Effects of Melatonin on Radiation-Induced Cataract. J. Radiat. Res. 46: 277-282.
46. Majsterek, I., Gloc, E., Blasiak, J. and Reiter, R. J. (2005) A comparison of the action of amifostine and melatonin on DNA damaging effects and apoptosis induced by idarubicin in normal and cancer cells. J. Pineal Res. 38: 254-263.
47. Rodriguez, C., Mayo, J. C., Sainz, R. M., Antolín, I., Herrera, F., Martín, V. and Reiter, R. J. (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 36: 1-9.
48. Reiter, R. J., Tan, D. X., Acuna-Castroviejo, D., Burkhardt, S. and Karbownik, M. (2000) Melatonin: mechanisms and actions as an antioxidant. Curr Topics Biophy. 24: 171-183.
49. Arvind, L. and Bhatia. A. L. (2004) Melatonin: Anti-Aging Perception and Current Perspectives In: Aging Interventions and Therapies, EDs. Suresh, I. S. and Rattan, pp. 147-169.
50. Blickenstaff, R. T., Brandstadter, S. M., Reddy, S. and Witt, R. (1994) Potential radioprotective agents: 1. Homologs of melatonin. J Pharm Sci. 83: 216-218.
51. Badr, F. M., Habit, O. H. E. and Harraz, M. M. (1999) Radioprotective effect of melatonin assessed by measuring chromosomal damage in mitotic and meiotic cells. Mutat Res. 444: 367-372.
52. Taysi, S., Koc, M., Buyukokuroglu, M. E., Alt?nkaynak, K. and Sahin, Y. N. (2003) Melatonin protects rat liver against irradiation-induced oxidative injury. J Radiat Res. 44: 211-217.
53. Manda, K. and Bhatia, A. L. (2003) Prophylactic action of melatonin against cyclophosphamide induced oxidative stress in mice. Cell Biol Toxicol. 19: 367-372.
54. Monobe, M., Hino, M., Sumi, M., Uzawa, A., Hirayama, R., Ando, K. and Kojima, S. (2005) Protective effects of melatonin on gamma -ray induced intestinal damage. Int. J. Radiat. Biol. 81: 855-860.
55. Blask, D. E., Sauer, L. A. and Dauchy, R. T. (2002) Melatonin as a Chronobiotic/Anticancer Agent: Cellular, Biochemical, and Molecular Mechanisms of Action and their Implications for Circadian-Based Cancer Therapy. Current Topics in Medicinal Chemistry. 2: 113-132.
56. Blask, D. E., Leonard, A., Sauer, R. T., Dauchy, E. W., Holowachuk, M. S. and Kopff, H. S. (1999) Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Research. 59: 4693-4701.
57. Cos, S., Mediavilla, M. D., Fernandez, R., GonzaIez-Lamuno, D. and Sanchez-Barcelo, E. J. D. (2002) Melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro. J Pineal Res. 32: 90-94.
58. Manda, K. and Bhatia, A. L. (2003a) Melatonin-induced reduction in age-related accumulation of oxidative damage in mice. Biogerontology. 4: 133-139.
59. Mills, E., Wu, P., Seely, D. and Guyatt, G. (2005) Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J. Pineal Res. 31: 360-366.
60. Vijayalaxmi, Thomas, C. R., Reiter, R. J. and Herman, T. S. (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol. 20: 2575-2601.
61. Blask, D. E., Sauer, L. A. and Dauchy, R. T. (2002) Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadianbased cancer therapy. Curr Top Med Chem. 2: 113-132.
62. Allegra, M., Reiter, R. J., Tan, D. X., Gentile, C., Tesoriere, L. and Livrea, M. A. (2003) The chemistry of melatonin's interaction with reactive species. J Pineal Res. 34: 1-10.
63. Blask, D. E., Dauchy, R. T., Sauer, L. A. and Krause, J. A. (2004) Melatonin uptake and growth prevention in rat hepatoma 7288 CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxydecadienoic acid and the potential role of phytomelatonin. Carcinogenesis. 25: 951-960.
64. Manda, K. and Bhatia, A. L. (2003b) Melatonin's anti-aging role: A study on LPO in mice tissues. Ind. J Gerontol. 6: 211-217.
65. Bhatia, A. L. and Manda, K. (2004) Study on pre-treatment of melatonin against radiation-induced oxidative stress in mice. Environmental Toxicology and Pharmacology. 18: 13-20.